Danske Bank’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24.9M Buy
47,228
+3,161
+7% +$1.77M 0.05% 279
2026
Q1
$24.8M Buy
44,067
+6
+0% +$3.85K 0.06% 259
2025
Q4
$29.8M Buy
44,061
+4,106
+10% +$2.8M 0.07% 232
2025
Q3
$25.5M Sell
39,955
-1,432
-3% -$869K 0.06% 253
2025
Q2
$22.2M Buy
41,387
+1,348
+3% +$645K 0.06% 270
2025
Q1
$16.8M Sell
40,039
-4,074
-9% -$1.77M 0.05% 301
2024
Q4
$18.2M Buy
44,113
+8,730
+25% +$3.83M 0.05% 294
2024
Q3
$17.9M Buy
35,383
+247
+0.7% +$120K 0.06% 274
2024
Q2
$17.1M Sell
35,136
-4,845
-12% -$2.43M 0.06% 258
2024
Q1
$21.6M Buy
+39,981
New +$21.8M 0.07% 255

Other funds holding IDXX

Danske Bank's IDXX Position: Q2 2026 in Review

Danske Bank increased its Idexx Laboratories (IDXX) stake by 7.2% in Q2 2026, buying an estimated $1.77M and bringing the position to 47,228 shares worth $24.9M. The position accounts for 0.05% of the portfolio, ranked #279.

Danske Bank first reported a position in IDXX in Q1 2024 and has held it in 10 quarters since. The position peaked at $29.8M in Q4 2025. 1,180 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Danske Bank held 47,228 shares of Idexx Laboratories worth $24.9M as of Q2 2026.
  • Danske Bank bought 3,161 Idexx Laboratories shares in Q2 2026, an estimated $1.77M.
  • Idexx Laboratories made up 0.05% of Danske Bank's portfolio in Q2 2026, its #279 holding.
  • Danske Bank first reported a position in Idexx Laboratories in Q1 2024 and has held it in 10 quarters since.
  • Danske Bank's Idexx Laboratories position peaked at $29.8M in Q4 2025.
  • 1,180 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Danske Bank's 13F filing for Q2 2026, filed 10 Aug 2026.